@inproceedings{inproceedings, title  = {{Dupilumab treatment is associated with reductions in serum immunoglobulin E and thymus and activation-regulated chemokine levels in children aged 6 to 11 years with severe atopic dermatitis}},

 url = {{}},

 year = {{2022}},

 month = {{1}},

 author = {{Cork MJ and Wollenberg A and Siegfried E and Chen Z and Levit NA and Rodriguez Marco A}},

 volume = {{52}},

 journal = {{CLINICAL AND EXPERIMENTAL ALLERGY}},

 issue = {{8}},

 pages = {{1059-1059}},

 note = {{Accessed on 2024/12/22}}}